{
    "eid": "2-s2.0-85061481162",
    "title": "5-O-acetyl-renieramycin T from blue sponge Xestospongia sp. Induces lung cancer stem cell apoptosis",
    "cover-date": "2019-02-11",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "5-O-acetyl-renieramycin T",
        "Anti-cancer",
        "Apoptosis",
        "Cisplatin",
        "Lung cancer",
        "Xestospongia sp"
    ],
    "authors": [
        "Wipa Chantarawong",
        "Supakarn Chamni",
        "Khanit Suwanborirux",
        "Naoki Saito",
        "Pithi Chanvorachote"
    ],
    "citedby-count": 21,
    "ref-count": 63,
    "ref-list": [
        "Drug development from marine natural products",
        "Impact of natural products on developing new anti-cancer agents",
        "Cancer stem cells: An insight",
        "Cancer stem cells as key drivers of tumour progression",
        "Lung cancer stem cells: A biological and clinical perspective",
        "Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity",
        "Drug-selected human lung cancer stem cells: Cytokine network, tumorigenic and metastatic properties",
        "Lung cancer stem cells: The root of resistance",
        "Utilization of lung cancer cell lines for the study of lung cancer stem cells (Review)",
        "CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients",
        "Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling",
        "Activation of \u03b2-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters",
        "Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+primary colon cancer cells",
        "Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics",
        "Bioactive isoquinoline quinone from an undescribed Philippine marine sponge of the genus Xestospongia",
        "Chemistry of renieramycins. Part 3. Isolation and structure of stabilized renieramycin type derivatives possessing antitumor activity from Thai sponge Xestospongia species, pretreated with potassium cyanide",
        "Chemistry of renieramycins. Part 5. Structure elucidation of renieramycin-type derivatives O, Q, R, and S from Thai marine sponge Xestospongia species pretreated with potassium cyanide",
        "Chemistry of renieramycins. 17. A new generation of renieramycins: Hydroquinone 5-O-monoester analogues of renieramycin M as potential cytotoxic agents against non-small-cell lung cancer cells",
        "Chemistry of renieramycins. Part 13: Isolation and structure of stabilized renieramycin type derivatives, renieramycins W-Y, from Philippine blue sponge Xestospongia sp., pretreated with potassium cyanide",
        "Tetrahydroisoquinolines in therapeutics: A patent review (2010-2015)",
        "Stereoselective total synthesis of (\u2212)-renieramycin T",
        "Construction of the pentacyclic core and formal total synthesis of (rac)-renieramycin T",
        "Chemistry of renieramycins. Part 7: Renieramycins T and aU, novel renieramycin-ecteinascidin hybrid marine natural products from Thai sponge Xestospongia sp",
        "Chemistry of renieramycins. Part 8: Synthesis and cytotoxicity evaluation of renieramycin M-jorunnamycin A analogues",
        "Apoptosis: A link between cancer genetics and chemotherapy",
        "The genetics of the p53 pathway, apoptosis and cancer therapy",
        "Caspase control: Protagonists of cancer cell apoptosis",
        "Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer",
        "Nitric oxide and aggressive behavior of lung cancer cells",
        "Requirement for ERK activation in cisplatin-induced apoptosis",
        "Coping with stress: Multiple ways to activate p53",
        "P53 family and cellular stress responses in cancer",
        "Cisplatin in cancer therapy: Molecular mechanisms of action",
        "Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer",
        "Molecular mechanisms of cisplatin resistance",
        "Increasing P53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro",
        "Interferon regulatory factor 4 binding protein is a novel p53 target gene and suppresses cisplatin-induced apoptosis of breast cancer cells",
        "Apigenin enhances the cisplatin cytotoxic effect through p53-modulated apoptosis",
        "Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin",
        "MAPK/ERK activation sensitizes MKN-28 cells to cisplatin-induced apoptosis",
        "Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway",
        "Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistance",
        "Upregulation of bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines",
        "Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure",
        "Bcl-2 and Bcl-xL mediate resistance to receptor tyrosine kinase targeted therapy in lung and gastric cancer",
        "Activation of ERK-p53 and ERK-mediated phosphorylation of Bcl-2 are involved in autophagic cell death induced by the c-Met inhibitor SU11274 in human lung cancer A549 cells",
        "Bcl-2 family in non-small cell lung cancer: Its prognostic and therapeutic implications",
        "The biology of cancer stem cells",
        "Suppression of cancer stem-like phenotypes in NCI-H460 lung cancer cells by vanillin through an Akt-dependent pathway",
        "The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations",
        "Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma",
        "CD133 expression: A potential prognostic marker for non-small cell lung cancers",
        "Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties",
        "Lung cancer stem cells and cancer stem cell-targeting natural compounds",
        "Targeting signaling pathways in cancer stem cells for cancer treatment",
        "Cancer stem cell signaling pathways",
        "Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment",
        "RaS interaction with PI3K",
        "CD44 promotes cell proliferation in non-small cell lung cancer",
        "Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature",
        "Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment",
        "CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kiyose",
            "@id": "60025065",
            "affilname": "Meiji Pharmaceutical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025065",
            "affiliation-country": "Japan"
        }
    ],
    "funding": [
        "JSPS",
        "Chulalongkorn University",
        "Thailand Research Fund"
    ]
}